Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 6 EP applications Oliver Löwrick has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after November 06, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12799541

INSULIN GLARGINE VERSUS METFORMIN FOR THE FIRST-LINE TREATMENT OF EARLY TYPE 2 DIABETES

IPC classification:
A61K 38/28, A61P 3/10
Applicant:
Sanofi, S.A.
Agent:
Oliver Löwrick, Sanofi-Aventis Deutschland GmbH
Status:
APPLICATION WITHDRAWN
EP13713425

BASAL INSULIN THERAPY

IPC classification:
A61K 38/28, A61P 9/10, A61P 3/10
Applicant:
Sanofi-Aventis Deutschland GmbH
Applicant:
Sanofi, S.A.
Agent:
Oliver Löwrick, Sanofi-Aventis Deutschland GmbH
Status:
GRANT OF PATENT INTENDED
EP14305886

A novel soluble biomarker for insulin resistance

IPC classification:
G01N 33/68
Applicant:
Sanofi, S.A.
Applicant:
Universität Leipzig KöR
Agent:
Oliver Löwrick, Sanofi-Aventis Deutschland GmbH
Status:
APPLICATION REFUSED
EP12701015

PHARMACEUTICAL COMPOSITIONS COMPRISING HUMAN ANTIBODIES TO PCSK9

IPC classification:
A61P 3/06, A61K 39/395, C07K 16/40
Applicant:
Sanofi, S.A.
Agent:
Oliver Löwrick, Sanofi-Aventis Deutschland GmbH
Agent:
Jörk Zwicker, Zwicker Schnappauf & Partner Patentanwälte PartG mbB (ZSP)
Status:
EXAMINATION IN PROGRESS
EP14714692

TREATMENT OF DIABETES MELLITUS BY LONG ACTING FORMULATIONS OF INSULINS

IPC classification:
A61P 3/10, A61K 9/00, A61K 38/28
Applicant:
Sanofi, S.A.
Agent:
Oliver Löwrick, Sanofi-Aventis Deutschland GmbH
Status:
EXAMINATION IN PROGRESS
EP15719657

NEW ADMINISTRATION ROUTES OF INSULIN, INSULIN ANALOGS OR DERIVATIVES OF INSULIN

IPC classification:
A61P 7/12, A61K 38/28
Applicant:
Sanofi, S.A.
Agent:
Herzog Fiesser & Partner Patentanwälte PartG mbB
Agent:
Oliver Löwrick, Sanofi-Aventis Deutschland GmbH
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature